|
[1]
|
Torre, L.A., Bray, F., Siegel, R.L., et al. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Li, T., Guo, H., Zhao, X., et al. (2016) Gastric Cancer Cell Proliferation and Survival Is Enabled by a Cyclophilin B/STAT3/miR-520d-5p Signaling Feedback Loop. Cancer Research, 77, 1225.
[Google Scholar] [CrossRef]
|
|
[3]
|
Chen, W., Zheng, R., Zhang, S., et al. (2014) Annual Report Status of Cancer in China, 2010. Chinese Journal of Cancer Research, 26, 48-58. [Google Scholar] [CrossRef]
|
|
[4]
|
Andal, N., Shanthi, P., Krishnan, K.B., et al. (2003) The Epstein Barr Virus and Gastric Carcinoma. Indian Journal of Pathology & Microbiology, 46, 34-36.
|
|
[5]
|
Camargo, M.C., Kim, W.H., Chiaravalli, A.M., et al. (2014) Improved Survival of Gastric Cancer with Tumour Epstein-Barr Virus Positivity: An International Pooled Analysis. Gut, 63, 236-243.
[Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wang, F., Sun, G., Zou, Y., et al. (2013) Protective Role of Helicobacter pylori Infection in Prognosis of Gastric Cancer: Evidence from 2454 Patients with Gastric Cancer. PLoS ONE, 8, 62440-62447.
[Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
吴赛青, 欧阳劲光, 窦红漫, 等. 三种胃幽门螺杆菌检测方法比较[J]. 临床与实验病理学杂志, 2019, 35(4): 486-487.
|
|
[8]
|
De Souza, C.R., de Oliveira, K.S., Ferraz, J.J., et al. (2014) Occurrence of Helicobacter pylori and Epstein Barr Virus Infection in Endoscopic and Gastric Cancer Patients from Northern Brazil. BMC Gastroenterology, 14, 179-183.
[Google Scholar] [CrossRef]
|
|
[9]
|
Tsao, S.W., Tsang, C.M., Pang, P.S., et al. (2012) Te Biology of EBV Infection in Human Epithelial Cells. Seminars in Cancer Biology, 22, 137-143. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Iwakiri, D., Minamitani, T. and Samanta, M. (2013) Epstein-Barr Virus Latent Membrane Protein 2A Contributes to Anoikis Resistance through ERK Activation. Journal of Virology, 87, 8227-8234.
[Google Scholar] [CrossRef]
|
|
[11]
|
Zhang, Y.W., Zhao, X.X., Tan, C., et al. (2014) Epstein-Barr Virus Latent Membrane Protein 2A Suppresses the Expression of HER2 via a Pathway Involving TWIST and YB-1 in Epstein-Barr Virus-Associated Gastric Carcinomas. Oncotarget, 6, 207-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
李北芳, 高静. EBV相关性胃癌罕见p53基因突变的可能机制与意义[J]. 中国肿瘤临床, 2017, 44(11): 522-526.
|
|
[13]
|
Ishii, H., Gobe, G., Kawakubo, Y., et al. (2001) Interrelationship between Eptein-Barr Virus Infection in Gastric Carcinomas and the Expression of Apoptosis-Associated Proteins. Histopathology, 38, 111-119.
[Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
王治兰, 贾淑娟, 陈俊红. 幽门螺杆菌感染与胃癌组织中HER2表达的相关性研究[J]. 中国现代医生, 2015, 53(24): 14-16.
|
|
[15]
|
杨勇, 赵子龙, 周国江. 幽门螺杆菌感染与胃癌组织中HER2表达的相关性研究[J]. 实用临床医药杂志, 2017, 21(23): 222-223.
|
|
[16]
|
魏茜, 余树林, 黄宜峰. 胃癌组织中P53、IL-1β、NF-κB的表达及与幽门螺杆菌感染的相关性分析[J]. 中国中西医结合消化杂志, 2019, 27(3): 228-231.
|
|
[17]
|
王名法, 刘友斌. XPF、p53蛋白在胃癌组织中的表达及与幽门螺杆菌L型感染的关系[J]. 临床与实验病理学杂志, 2015, 31(10): 1089-1094.
|
|
[18]
|
Yu, X.W., Xu, Y., Gong, Y.H., et al. (2011) Helicobacter pylori Induces Malignant Transformation of Gastric Epithelial Cells in Vitro. APMIS, 119, 187-197. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
刘爱群, 葛莲英, 罗元, 等. 胃癌变过程中Hp感染与凋亡基因Bcl-2表达相关性研究[J]. 广西医学, 2011, 4(32): 444-446.
|
|
[20]
|
吴峰阶, 朱君, 赵大华, 等. 幽门螺杆菌感染与胃癌组织中Ki-67及EGFR表达的关系[J]. 临床普外科电子杂志, 2017, 5(3): 14-19.
|
|
[21]
|
Szkaradkiewicz, A., Karpinski, T.M., Majewski, J., et al. (2015) Te Participation of p53 and bcl-2 Proteins in Gastric Carcinomas Associated with Helicobacter pylori and/or Epstein-Barr Virus (EBV). Polish Journal of Microbiology, 64, 211-216. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Flores-Luna, L., Camorlinga-Ponce, M., Hernandez-Suarez, G., et al. (2012) The Utility of Serologic Tests as Biomarkers for Helicobacter pylori-Associated Precancerous Lesions and Gastric Cancer Varies between Latin American Countries. Cancer Causes Control, 24, 241-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
杨艳丽, 胡建国, 司岑. EBV、Hp感染与胃癌的关系及相互作用研究[J]. 天津医药, 2013, 41(11): 1048-1051.
|